U.S. to pay $1.5B for Moderna's COVID-19 vaccine

By The Science Advisory Board staff writers

August 12, 2020 -- The U.S. government awarded a maximum $1.525 billion contract to Moderna to secure 100 million doses of its messenger RNA (mRNA) COVID-19 vaccine.

The government signed the deal for Moderna's mRNA-1273 vaccine through its Operation Warp Speed project. The deal includes an option to buy an additional 400 million doses of the vaccine in the future. Americans will receive the vaccine at no cost for the vaccine itself.

This new contract covers the manufacturing and delivery of 100 million doses, including incentive payments for their timely delivery. These funds, along with the previous award of up to $955 million from the U.S. Biomedical Advanced Research and Development Authority for the development of the vaccine, totals up to $2.48 billion.

In July, Moderna announced that its vaccine was safe and triggered immune responses in healthy adults.

Copyright © 2020 scienceboard.net

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Email Preferences

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.